Please login to the form below

Not currently logged in
Email:
Password:

Bayer's Kirstyn Nicholas joins Spirit Healthcare

Takes up role as regional business director

edit-Spirit-Healthcare-Kirstyn-NicholasLeicestershire, UK, based Spirit Healthcare has named Kirstyn Nicholas as regional business director.

Nicholas joins from Bayer, where she was principal territory manager for almost ten years.

The role included working with CCG leads, consultants and clinical scientists and prior to that she worked as healthcare development manager at Bayer HealthCare.

Commenting on her appointment, Nicholas said: “I am thrilled to be working for such a refreshingly innovative company that provides a range of high quality products and solution as well as the internal knowledge, passion and commitment to improve patient lives.”

Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.

Chris Barker, chief executive of Spirit Healthcare, added: “Kirstyn has only been with the company a few weeks and has already made a significant contribution. It is great to have such talent on the team as we continue to expand.”

The expansion follows the successful launch of EMPOWER Structured Diabetes Education and the introduction of TEE2 to its diabetes portfolio.

Spirit Healthcare is a provider of healthcare solution to the NHS and private hospitals, recently winning a PMEA award for Excellence in Healthcare Collaboration and Partnerships Leicester City TotalCare Project.

11th February 2015

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics